Page last updated: 2024-11-01

ondansetron and Duodenal Ulcer

ondansetron has been researched along with Duodenal Ulcer in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.

Research Excerpts

ExcerptRelevanceReference
"The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer."7.75Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009)
"The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer."3.75Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramesh, ST1
Asad, M1
Dhamanigi, SS1
Prasad, VS1

Other Studies

1 other study available for ondansetron and Duodenal Ulcer

ArticleYear
Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers.
    Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:3

    Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Ac

2009